FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Semaglutide Tablet
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Novo Nordisk, Inc. (New 06/04/2026)

Company Contact Information:
833-493-4689

Presentation	Posting Date	Related Information
Rybelsus, Tablet, 3 mg (NDC 0169-4303-30)	06/04/2026	Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.
Rybelsus, Tablet, 7 mg (NDC 0169-4307-30)	06/04/2026	Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.
Rybelsus, Tablet, 14 mg (NDC 0169-4314-30)	06/04/2026	Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.